Your account is not claimed yet. You can sign up with ORCID to claim your account.

Xiaoyan Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Cancer research communications

Virologica Sinica

Nature microbiology

Science signaling

Fudan University School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fudan University School of Medicine Jun 1o 2009

China

Prof. :: IBS/SPHCC

Publications

Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1 + CD8 + T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer. Cancer research communications 3 (6) (2023)
Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1 + CD8 + T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer. Cancer research communications 3 (6) (2023)
Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1 + CD8 + T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer. Cancer research communications 3 (6) (2023)
Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1 + CD8 + T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer. Cancer research communications 3 (6) (2023)
Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1 + CD8 + T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer. Cancer research communications 3 (6) (2023)
Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu, Longfei Ding, Shuai Xia, Xingchen Chen, Mu Liu, Chenjian Gu, Xiao Lu, Yadong Fu, Shuangfeng Chen, Tianlong Zhang, Yaguang Zhang, Zhuo Yang, Liyan Ma, Wangpeng Gu, Gaowei Hu, Shujuan Du, Renhong Yan, Weihui Fu, Songhua Yuan, Chenli Qiu, Chen Zhao, Xiaoyan Zhang, Yonghui He, Aidong Qu, Xu Zhou, Xiuling Li, Gary Wong, Qiang Deng, Qiang Zhou, Hongzhou Lu, Zhiyang Ling, Jianping Ding, Lu Lu, Jianqing Xu, You-Hua Xie, Bing Sun
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2. Nature microbiology 7 (7) (2022)
Xiangqing Ding, Kangli Cao, Jing Wang, Yanmin Wan, Qinyun Chen, Yanqin Ren, Yongtang Zheng, Mingzhao Zhu, Renrong Tian, Wenjun Wang, Chen Zhao, Xiaoyan Zhang, Jianqing Xu
Exploration of a Sequential Gp140-Gp145 Immunization Regimen with Heterologous Envs to Induce a Protective Cross-Reactive HIV Neutralizing Antibody Response In Non-human Primates. Virologica Sinica 36 (4) (2021)
Xiangchuan He, Longfei Ding, Kangli Cao, Haoran Peng, Chenjian Gu, Yutang Li, Duoduo Li, Lanlan Dong, Xiujing Hong, Xiangwei Wang, Meilan Fu, Chenli Qiu, Cuisong Zhu, Ziling Zhang, Shu Song, Chenguang Wang, Zhengfan Jiang, Youhua Xie, Zhongtian Qi, Chen Zhao, Ping Zhao, Xiaoyan Zhang, Jianqing Xu
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge. Emerging microbes & infections 10 (1) (2021)
Yunyu Mao, Chen Zhao, Peiyong Zheng, Xiaoyan Zhang, Jianqing Xu
Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy. Immunotherapy 13 (2) (2020)
Ye Chen, Qibin Liao, Tianyue Chen, Yuchao Zhang, Wei-En Yuan, Jianqing Xu, Xiaoyan Zhang
Freeze-Drying Formulations Increased the Adenovirus and Poxvirus Vaccine Storage Times and Antigen Stabilities. Virologica Sinica 36 (3) (2020)
Xiangchuan He, Miaomiao Zhang, Chen Zhao, Peiyong Zheng, Xiaoyan Zhang, Jianqing Xu
From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD). Virologica Sinica 36 (2) (2020)
Yongquan He, Weihui Fu, Kangli Cao, Qian He, Xiangqing Ding, Jian Chen, Lingyan Zhu, Tianyue Chen, Longfei Ding, Yu Yang, Cuisong Zhu, Songhua Yuan, Zejun Li, Chen Zhao, Xiaoyan Zhang, Jianqing Xu
IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis. Science signaling 13 (626) (2020)
Wei Zhang, Li Xu, Xiaoyan Zhang, Jianqing Xu, Jun-O Jin
CD8α- conventional dendritic cells control Vβ T-cell immunity in response to Staphylococcus aureus infection in mice. Immunology 159 (4) (2020)
Jian Chen, Yi-Feng Yang, Yu Yang, Peng Zou, Jun Chen, Yongquan He, Sai-Lan Shui, Yan-Ru Cui, Ru Bai, Ya-Jun Liang, Yunwen Hu, Biao Jiang, Lu Lu, Xiaoyan Zhang, Jia Liu, Jianqing Xu
AXL promotes Zika virus infection in astrocytes by antagonizing type I interferon signalling. Nature microbiology 3 (3) (2018)

Xiaoyan Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xiaoyan Zhang